Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience

NCT04730323 is registered in ClinicalTrials.gov with FMH College of Medicine and Dentistry as lead sponsor.

NCT NCT04730323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04730323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience
Lead sponsor
FMH College of Medicine and Dentistry
Phase
Phase 4
Overall status
Completed
Start date
May 12, 2020
Completion date
June 12, 2020
Enrollment
93 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19